Reducing trauma deaths in the UK

The Lancet

Volumn 382, Issue 9888, 2013, Pages 208-

  Bozzette, Alex ^a   Aeron Thomas, Amy ^a  

^a not available   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TRANEXAMIC ACID;

BLEEDING; BLOOD TRANSFUSION; CAUSE OF DEATH; HEALTH CARE COST; HUMAN; INJURY; LETTER; MORTALITY; PRIORITY JOURNAL; TRAFFIC ACCIDENT; UNITED KINGDOM; VICTIM; ERRATUM; ERROR;

EID: 84880419328     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(13)61597-4     Document Type: Letter

References (5)

1. Ker K, Kiriya J, Perel P, Edwards P, Shakur H, Roberts I. Avoidable mortality from giving tranexamic acid to bleeding trauma patients: an estimation based on WHO mortality data, a systematic literature review and data from the CRASH-2 trial. BMC Emergency Medicine 2012; 12: 3.
2. RASH-2 Collaborators. The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. Lancet 2011; 377: 1096-101.
3. Guerriero C, Cairns J, Perel P, et al. Costeff ectiveness analysis of administering tranexamic acid to bleeding trauma patients using evidence from the CRASH-2 trial. PLoS One 2011; 6: 5.
4. Shakur H, Roberts I, Piot P, et al. A promise to save 100 000 trauma patients. Lancet 2012; 380: 2062-63.
5. Department of Health Payment by Results Team. Draft payment by results guidance for 2013-2014. http://www.dh.gov.uk/health/2012/12/pbr-road-test/ (accessed Jan 31, 2013).